| NCT05607420 | Study Evaluating UCART20x22 in B-Cell Non-Hodgkin Lymphoma | RECRUITING | PHASE1, PHASE2 | 2022-11-01 | 2027-08 | 2027-08 |
| NCT04142619 | Study Evaluating Safety and Efficacy of UCART Targeting CS1 in Patients With Relapsed/Refractory Multiple Myeloma (MELANI-01) | TERMINATED | PHASE1 | 2019-11-21 | 2023-06-18 | 2023-06-18 |
| NCT04150497 | Phase 1/2 Study of UCART22 in Patients With Relapsed or Refractory CD22+ B-cell Acute Lymphoblastic Leukemia (BALLI-01) | RECRUITING | PHASE1, PHASE2 | 2019-10-14 | 2026-06-30 | 2026-06-30 |
| NCT04106076 | Phase I Study of UCART123 in Patient With Adverse Genetic Risk Acute Myeloid Leukemia | WITHDRAWN | PHASE1 | 2019-07-11 | 2019-12-05 | 2019-12-05 |
| NCT03203369 | Study to Evaluate the Safety and Clinical Activity of UCART123 in Patients With BPDCN | TERMINATED | PHASE1 | 2017-06-28 | 2019-06-27 | 2019-06-27 |
| NCT03190278 | Study Evaluating Safety and Efficacy of UCART123v1.2 in Patients With Relapsed/Refractory Acute Myeloid Leukemia | ACTIVE_NOT_RECRUITING | PHASE1 | 2017-06-19 | 2025-12 | 2024-12-24 |